The designation Histone H3F3C Activators refers to a class of molecules that specifically engage with the histone variant H3F3C to modulate its function within the context of chromatin structure and gene expression regulation. Histones, including H3F3C, play a critical role in the organization of DNA within the nucleus by forming nucleosomes, around which DNA is wound. Activators of H3F3C would likely function by promoting the deposition of this histone variant into chromatin, influencing the interaction of H3F3C with other histone proteins and DNA, or facilitating post-translational modifications that affect H3F3C's role in chromatin remodeling and gene expression. The process by which these activators exert their effect could involve direct binding to H3F3C, resulting in a conformational change or recruitment of additional factors that assist in its incorporation into nucleosomes. These activators could also potentially enhance the rate at which H3F3C is assembled into chromatin by affecting the interaction between H3F3C and histone chaperones or other components of the nucleosome assembly pathway. Screening for such activators would likely involve in vitro assays that measure the incorporation of H3F3C into synthetic nucleosomes or changes in the accessibility of chromatinized DNA.
In order to fully characterize Histone H3F3C Activators, a multi-faceted approach would be necessary. Biochemical assays would need to be developed to measure the direct effect of potential activators on the dynamics of H3F3C nucleosome assembly and disassembly. These assays might include methods such as fluorescence resonance energy transfer (FRET) to monitor nucleosome assembly in real-time, or analytical ultracentrifugation to assess the stoichiometry and stability of nucleosomes containing H3F3C. Additionally, biophysical techniques like isothermal titration calorimetry (ITC) or differential scanning calorimetry (DSC) could be employed to quantify the thermodynamic parameters of activator binding to H3F3C or its nucleosomes. Structural studies, including X-ray crystallography or cryo-electron microscopy, would be critical for visualizing the interaction between H3F3C and these activators at an atomic level to determine the precise binding sites and conformational changes involved in activation. Moreover, mass spectrometry could be utilized to identify and quantify post-translational modifications on H3F3C that may be influenced by the presence of activators. Together, these techniques would offer a comprehensive understanding of how Histone H3F3C Activators interact with their target, providing valuable insights into the regulation of chromatin structure and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor can result in a more open chromatin state, potentially leading to increased H3.3 deposition at active genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is another histone deacetylase inhibitor, potentially increasing H3.3 incorporation by changing chromatin dynamics. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate can alter chromatin structure, potentially affecting H3.3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may lead to DNA demethylation, affecting chromatin remodeling and possibly H3.3 expression. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $36.00 $88.00 $220.00 $436.00 | 8 | |
Mimosine can induce DNA damage responses and cell cycle arrest, which could influence H3.3 expression during DNA repair processes. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
As a ribonucleotide reductase inhibitor, hydroxyurea can induce replication stress, potentially altering H3.3 dynamics during DNA repair. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin causes DNA crosslinking and damage, which may require remodeling of chromatin, potentially involving H3.3 incorporation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, leading to DNA synthesis and repair alterations, possibly affecting H3.3 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide induces DNA strand breaks, which may involve chromatin remodeling and subsequent changes in H3.3 incorporation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine affects several cellular processes, including cell cycle checkpoints and DNA repair, which could influence H3.3 expression. | ||||||